MGLL and Alzheimer disease: Monoacylglycerol lipase is the main enzyme responsible for the hydrolysis of the endocannabinoid 2-arachidonylglycerol, whose expression was shown to be correlated with disease progression in the hippocampi of AD patients [63,64].